Article Information
History
- October 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alfredo Mendrone-Junior1,6,
- Carla Luana Dinardo1,6,*,
- Suzete Cleuza Ferreira1,
- Anna Nishia1,
- Nanci Alves Salles1,
- Cesar de Almeida Neto1,
- Debora Toshei Hamasaki1,
- Tila Facincani1,
- Lucas Bassolli de Oliveira Alves2,
- Rafael Rahal Guaragna Machado4,
- Danielle Bastos Araujo4,
- Edison Luiz Durigon4,5,
- Vanderson Rocha1,2,6 and
- Ester Cerdeira Sabino3
- 1Fundação Pro Sangue Hemocentro de São Paulo, São Paulo, Brazil
- 2Serviço de Hematologia, Hemoterapia e Terapia Celular – HCFMUSP, São Paulo, Brazil
- 3Instituto de Medicina Tropical, FMUSP, São Paulo, Brazil
- 4Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil
- 5Scientific Platform Pasteur USP, São Paulo, Brazil
- 6Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil
- ↵* Corresponding author; email: caludinardo{at}gmail.com
Posted October 14, 2020.
CORRELATION BETWEEN SARS-COV-2 ANTIBODY SCREENING BY IMMUNOASSAY AND NEUTRALIZING ANTIBODY TESTING
